Complement activation is a secondary rather than a causative factor in rabbit pulmonary artery ischemia/reperfusion injury
- PMID: 1990958
- DOI: 10.1164/ajrccm/143.2.386
Complement activation is a secondary rather than a causative factor in rabbit pulmonary artery ischemia/reperfusion injury
Abstract
We have previously demonstrated that reperfusion of a rabbit lung in vivo after 24 h of unilateral pulmonary artery occlusion results in edema, transient leukopenia, and intravascular leukocyte aggregation. We hypothesized that complement was activated by reperfusion and that this in turn contributed to lung injury. In the preliminary phase of the study, we found that ischemia followed by reperfusion resulted in a drop in C3 to 15 +/- 10% (mean +/- SEM) of the prereperfusion value as compared with no change in a group of control animals that had undergone an identical thoracotomy but without pulmonary artery occlusion and reperfusion (p less than 0.05). We then studied three groups of animals to determine if complement depletion with cobra venom factor (CVF) prior to ischemia and reperfusion would prevent the injury. Rabbits treated with CVF but without occlusion and reperfusion did not develop significant lung edema, with left and right lung wet/dry ratios of 5.32 +/- 0.11 and 5.26 +/- 0.12, respectively. For rabbits that were not treated with CVF but underwent ischemia and reperfusion, the comparable numbers were 6.15 +/- 0.36 and 5.19 +/- 0.32 (p less than 0.05 for right versus left). For CVF-treated rabbits that underwent ischemia and reperfusion, the right/left difference persisted (6.77 +/- 0.48 versus 5.35 +/- 0.14, p less than 0.01). Immunocytochemistry documented C3 deposition in non-CVF rabbits that underwent ischemia and reperfusion but not in CVF-treated rabbits. We conclude that ischemia/reperfusion of the lung results in complement activation, but it is not a complement-dependent injury.
Similar articles
-
Pre-treatment with Cobra venom factor alleviates acute lung injury induced by intestinal ischemia-reperfusion in rats.Eur Rev Med Pharmacol Sci. 2013 Aug;17(16):2207-17. Eur Rev Med Pharmacol Sci. 2013. PMID: 23893188
-
Additive effect of intravascular complement activation and brief episodes of hypoxia in producing increased permeability in the rabbit lung.J Clin Invest. 1985 Mar;75(3):902-10. doi: 10.1172/JCI111790. J Clin Invest. 1985. PMID: 3980730 Free PMC article.
-
Cobra Venom Factor-induced complement depletion protects against lung ischemia reperfusion injury through alleviating blood-air barrier damage.Sci Rep. 2018 Jul 9;8(1):10346. doi: 10.1038/s41598-018-28724-z. Sci Rep. 2018. PMID: 29985461 Free PMC article.
-
Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseases.Thromb Haemost. 2015 Mar;113(3):548-52. doi: 10.1160/TH14-04-0300. Epub 2014 Jul 17. Thromb Haemost. 2015. PMID: 25031089 Review.
-
Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease models.Mol Immunol. 2014 Oct;61(2):191-203. doi: 10.1016/j.molimm.2014.06.035. Epub 2014 Jul 22. Mol Immunol. 2014. PMID: 25062833 Review.
Cited by
-
Plasma complement levels are associated with primary graft dysfunction and mortality after lung transplantation.Am J Respir Crit Care Med. 2014 Jun 15;189(12):1564-7. doi: 10.1164/rccm.201312-2121LE. Am J Respir Crit Care Med. 2014. PMID: 24930532 Free PMC article. Clinical Trial. No abstract available.
-
Complement system in lung disease.Am J Respir Cell Mol Biol. 2014 Oct;51(4):467-73. doi: 10.1165/rcmb.2013-0485TR. Am J Respir Cell Mol Biol. 2014. PMID: 24901241 Free PMC article. Review.
-
Inflammatory response to pulmonary ischemia-reperfusion injury.Surg Today. 2006;36(3):205-14. doi: 10.1007/s00595-005-3124-2. Surg Today. 2006. PMID: 16493527 Review.
-
Inhibition of complement activation by recombinant Sh-CRIT-ed1 analogues.Immunology. 2003 Sep;110(1):73-9. doi: 10.1046/j.1365-2567.2003.01706.x. Immunology. 2003. PMID: 12941143 Free PMC article.
-
Temporal correlation between postreperfusion complement deposition and severe primary graft dysfunction in lung allografts.Am J Transplant. 2024 Apr;24(4):577-590. doi: 10.1016/j.ajt.2023.11.006. Epub 2023 Nov 15. Am J Transplant. 2024. PMID: 37977230 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous